Llwytho...
Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2
BACKGROUND: Neutralizing antibodies (nAbs) against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) can play an important role in reducing impacts of the COVID-19 pandemic, complementing ongoing public health efforts such as diagnostics and vaccination. Rapidly designing, manufacturing a...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Antib Ther |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8022923/ https://ncbi.nlm.nih.gov/pubmed/33928236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tbab006 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|